130 results on '"Lohmann, Philipp"'
Search Results
2. Example of Artificial Intelligence–Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management
3. Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
4. Structural connectome-based predictive modeling of cognitive deficits in treated glioma patients
5. Clinical Applications of Radiomics in Nuclear Medicine
6. NIMG-05. CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF BRAIN METASTASES AFTER TREATMENT WITH STEREOTACTIC RADIOSURGERY USING SERIAL FET PET IMAGING
7. NIMG-20. ASSESSMENT OF RESPONSE TO REGORAFENIB IN RECURRENT GLIOMA PATIENTS USING FET PET AND MRI INCLUDING ADC VALUES
8. NCOG-04. WHOLE-BRAIN STRUCTURAL CONNECTIVITY PREDICTS COGNITIVE DEFICITS IN PRETREATED PATIENTS WITH CNS WHO GRADE 3 OR 4 GLIOMAS
9. Diagnostic Accuracy of MR Spectroscopic Imaging and18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
10. Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI
11. Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
12. Evolution and Implementation of Radiographic Response Criteria in Neuro-oncology
13. The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine
14. Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET
15. Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
16. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer
17. Hybrid PET/MRI in Neuro-oncology: Current Status and Perspectives
18. FET and FDOPA PET Imaging in Glioma
19. Assessment of brain tumour perfusion using early-phase 18F-FET -PET: comparison with perfusion-weighted MRI
20. Amino Acid PET in Neurooncology
21. Supplemental Figure 1 from Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
22. Supplemental Figure 1 from Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
23. The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis
24. The impact of brain lesions on quality of life in patients with WHO CNS grade 3 or 4 glioma: A lesion-function and resting-state fMRI analysis
25. Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
26. Imaging patterns in patients with newly diagnosed glioblastoma in England
27. Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
28. An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET
29. NIMG-28. USE OF NEUROIMAGING TECHNIQUES IN GLIOMA PATIENTS – RESULTS OF AN INTERNATIONAL SURVEY ON BEHALF OF THE EORTC BRAIN TUMOR GROUP
30. NIMG-27. THE PROGNOSTIC VALUE OF FET PET IN PATIENTS WITH RECURRENT GLIOMA TREATED WITH BEVACIZUMAB
31. NIMG-83. MULTIMODAL PET/MRI RADIOMICS AND CLINICAL PARAMETERS FOR OVERALL SURVIVAL PREDICTION IN PATIENTS WITH IDH WILDTYPE GLIOBLASTOMA
32. NIMG-84. PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RECURRENCE USING MRI AND FET PET
33. Radiomics in neuro-oncological clinical trials
34. Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET
35. Editorial: “Nuclear medicine in cancer diagnosis”
36. Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
37. Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
38. The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomas
39. Use of advanced neuroimaging and artificial intelligence in meningiomas
40. Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases
41. Use of neuroimaging techniques in glioma patients – results of an international survey on behalf of the EORTC brain tumor group
42. Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases
43. NIMG-27. REGORAFENIB RESPONSE ASSESSMENT USING FET PET IN PATIENTS WITH PROGRESSIVE GLIOMA
44. NIMG-06. CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF IRRADIATED BRAIN METASTASES USING SERIAL DYNAMIC FET PET IMAGING
45. NIMG-04. PREDICTING THE BRAF MUTATIONAL STATUS IN PATIENTS WITH MELANOMA BRAIN METASTASES USING RADIOMICS - A BICENTRIC STUDY
46. Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
47. Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
48. Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
49. 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection
50. A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.